fluorescein has been researched along with imatinib mesylate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, Y; Bakalova, R; Ewis, A; Ishikawa, M; Ohba, H; Shinohara, Y; Zhelev, Z | 1 |
1 other study(ies) available for fluorescein and imatinib mesylate
| Article | Year |
|---|---|
Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study).
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Division; Cell Survival; DNA, Complementary; Enzyme Inhibitors; Fluorescein; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Lymphocytes; Microscopy, Confocal; Models, Molecular; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Transfection | 2004 |